Items where Author is "Zlobec, I."
Number of items: 27. 2016Dawson, H. and Novotny, A. and Becker, K. and Reim, D. and Langer, R. and Gullo, I. and Svrcek, M. and Niess, J. H. and Tutuian, R. and Truninger, K. and Diamantis, I. and Blank, A. and Zlobec, I. and Riddell, R. H. and Carneiro, F. and Flejou, J. F. and Genta, R. M. and Lugli, A.. (2016) Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte's autopsy report. Digestive and Liver Disease, 48 (11). pp. 1378-1385. 2013Droeser, R. A. and Hirt, C. and Viehl, C. T. and Frey, D. M. and Nebiker, C. and Huber, X. and Zlobec, I. and Eppenberger-Castori, S. and Tzankov, A. and Rosso, R. and Zuber, M. and Muraro, M. G. and Amicarella, F. and Cremonesi, E. and Heberer, M. and Iezzi, G. and Lugli, A. and Terracciano, L. and Sconocchia, G. and Oertli, D. and Spagnoli, G. C. and Tornillo, L.. (2013) Clinical impact of programmed cell death ligand 1 expression in colorectal cancer. European journal of cancer, Vol. 49, H. 9. pp. 2233-2242. Droeser, R. A. and Hirt, C. and Eppenberger-Castori, S. and Zlobec, I. and Viehl, C. T. and Frey, D. M. and Nebiker, C. A. and Rosso, R. and Zuber, M. and Amicarella, F. and Iezzi, G. and Sconocchia, G. and Heberer, M. and Lugli, A. and Tornillo, L. and Oertli, D. and Terracciano, L. and Spagnoli, G. C.. (2013) High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor. PLoS ONE, Vol. 8, H. 5 , e64814. Le Magnen, C. and Bubendorf, L. and Ruiz, C. and Zlobec, I. and Bachmann, A. and Heberer, M. and Spagnoli, G. C. and Wyler, S. and Mengus, C.. (2013) Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells. European journal of cancer, Vol. 49, H. 4. pp. 955-963. 2012Droeser, R. and Zlobec, I. and Kilic, E. and Guth, U. and Heberer, M. and Spagnoli, G. and Oertli, D. and Tapia, C.. (2012) Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers. BMC cancer, Vol. 12 , 134. 2011Karamitopoulou, E. and Zlobec, I. and Patsouris, Es and Peros, G. and Lugli, A.. (2011) Loss of E-cadherin independently predicts the lymph node status in colorectal cancer. Pathology, Vol. 43, H. 2. pp. 133-137. Cindolo, L. and Cantile, M. and Franco, R. and Chiodini, P. and Schiavo, G. and Forte, I. and Zlobec, I. and Salzano, L. and Botti, G. and Gidaro, S. and Terracciano, L. and Cillo, C.. (2011) Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers. International braz j urol, Vol. 37, H. 1. pp. 57-66. 2010Minoo, P. and Zlobec, I. and Peterson, M. and Terracciano, L. and Lugli, A.. (2010) Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. International journal of oncology, Vol. 37, H. 3. pp. 707-718. Zlobec, I. and Molinari, F. and Kovac, M. and Bihl, M. P. and Altermatt, H. J. and Diebold, J. and Frick, H. and Germer, M. and Horcic, M. and Montani, M. and Singer, G. and Yurtsever, H. and Zettl, A. and Terracciano, L. and Mazzucchelli, L. and Saletti, P. and Frattini, M. and Heinimann, K. and Lugli, A.. (2010) Prognostic and predictive value of TOPK stratified by KRAS and BRAF gene alterations in sporadic, hereditary and metastatic colorectal cancer patients. British journal of cancer, Vol. 102, no. 1. pp. 151-161. Lugli, A. and Iezzi, G. and Hostettler, I. and Muraro, M. G. and Mele, V. and Tornillo, L. and Carafa, V. and Spagnoli, G. and Terracciano, L. and Zlobec, I.. (2010) Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. British journal of cancer, Vol. 103, no. 3. pp. 382-390. Fischer, C. A. and Kampmann, M. and Zlobec, I. and Green, E. and Tornillo, L. and Lugli, A. and Wolfensberger, M. and Terracciano, L. M.. (2010) p16 expression in oropharyngeal cancer : : its impact on staging and prognosis compared with the conventional clinical staging parameters. Annals of oncology, Vol. 21, H. 10. pp. 1961-1966. 2009Lugli, A. and Karamitopoulou, E. and Panayiotides, I. and Karakitsos, P. and Rallis, G. and Peros, G. and Iezzi, G. and Spagnoli, G. and Bihl, M. and Terracciano, L. and Zlobec, I.. (2009) CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a 'pro-/anti-tumour' approach to tumour host interaction in colorectal cancer. British journal of cancer : the clinical and scientific journal of The Cancer Research Campaign : BJC, Vol. 101. pp. 1382-1392. Tapia, C. and Savic, S. and Bihl, M. and Rufle, A. and Zlobec, I. and Terracciano, L. and Bubendorf, L.. (2009) EGFR-Mutationsanalyse beim nichtkleinzelligen Lungenkarzinom. Der Pathologe : Pathologie und Klinik : Organ von: Internationale Akademie für Pathologie Deutsche Abteilung e.V. ... [et al.], Vol. 30. pp. 384-392. Baumhoer, D. and Riener, M. O. and Zlobec, I. and Tornillo, L. and Vogetseder, A. and Kristiansen, G. and Dietmaier, W. and Hartmann, A. and Wuensch, P. H. and Sessa, F. and Ruemmele, P. and Terracciano, L. M.. (2009) Expression of CD24, P-cadherin and S100A4 in tumors of the ampulla of Vater. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Vol. 22. pp. 306-313. Adams, H. and Tzankov, A. and Lugli, A. and Zlobec, I.. (2009) New time-dependent approach to analyse the prognostic significance of immunohistochemical biomarkers in colon cancer and diffuse large B-cell lymphoma. Journal of clinical pathology : the journal of the Association of Clinical Pathologists, Vol. 62. pp. 986-997. 2008Karamitopoulou, E. and Tornillo, L. and Zlobec, I. and Cioccari, L. and Carafa, V. and Borner, M. and Schaffner, T. and Brunner, T. and Diamantis, I. and Zimmermann, A. and Terracciano, L.. (2008) Clinical significance of cell cycle- and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immunophenotype for intrahepatic and extrahepatic cholangiocarcinomas. American Journal of Pathology, Vol. 130, no. 5. pp. 780-786. Zlobec, I. and Vuong, T. and Compton, C. C. and Lugli, A. and Michel, R. P. and Hayashi, S. and Jass, J. R.. (2008) Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy. British journal of cancer, Vol. 98 no. 2. pp. 450-456. Lugli, A. and Tzankov, A. and Zlobec, I. and Terracciano, L. M.. (2008) Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status. Modern pathology, Vol. 21, no. 11. pp. 1403-1412. Baumhoer, D. and Zlobec, I. and Tornillo, L. and Dietmaier, W. and Wuensch, P. H. and Hartmann, A. and Sessa, F. and Ruemmele, P. and Terracciano, L. M.. (2008) Immunophenotyping and oncogene amplifications in tumors of the papilla of Vater. Virchows Archiv, Vol. 453. pp. 579-588. Wetli, S. C. and Leuschner, I. and Harms, D. and Rufle, A. and Foerster, A. and Bihl, M. and Graf, N. and Furtwaengler, R. and Paulussen, M. and Briner, J. and Aslanidis, C. and Schmitz, G. and Tornillo, L. and Mihatsch, M. J. and Zlobec, I. and Bruder, E.. (2008) KIT, PDGFRalpha and EGFR analysis in nephroblastoma. Virchows Archiv, Vol. 452. pp. 637-650. Zlobec, I. and Terracciano, L. M. and Lugli, A.. (2008) Local recurrence in mismatch repair-proficient colon cancer predicted by an infiltrative tumor border and lack of CD8+ tumor-infiltrating lymphocytes. Clinical cancer research, Vol. 14. pp. 3792-3797. Zlobec, I. and Minoo, P. and Baumhoer, D. and Baker, K. and Terracciano, L. and Jass, J. R. and Lugli, A.. (2008) Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer. Cancer, Vol. 112, H. 3. pp. 495-502. Zlobec, I. and Baker, K. and Minoo, P. and Jass, J. R. and Terracciano, L. and Lugli, A.. (2008) Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Clinical cancer research, Vol. 14. pp. 143-148. Zlobec, I. and Lugli, A.. (2008) Prognostic and predictive factors in colorectal cancer. Journal of clinical pathology, Vol. 61. pp. 561-569. Zlobec, I. and Baker, K. and Terracciano, L. M. and Lugli, A.. (2008) RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis. Clinical cancer research, Vol. 14. pp. 3798-3806. Zlobec, I. and Terracciano, L. and Tornillo, L. and Günthert, U. and Vuong, T. and Jass, J. R. and Lugli, A.. (2008) Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer. Gut, 57 (10). pp. 1413-1419. Zlobec, I. and Baker, K. and Terracciano, L. and Peter, S. and Degen, L. and Beglinger, C. and Lugli, A.. (2008) Two-marker protein profile predicts poor prognosis in patients with early rectal cancer. British journal of cancer, Vol. 99, no. 10. pp. 1712-1717. |
